RNA Outsourcing Resources
-
How Operational Efficiency Shapes Late-Phase Manufacturability
6/26/2026
Prioritize operational efficiency over early-stage flexibility to scale advanced therapies. Standardized workflows and qualified shipping lanes reduce variability for predictable late-phase success.
-
Shifting The Approach: 4 Tactics For ICH E6(R3) Implementation
4/30/2024
In addition to codifying some best practices, R3 recommends that sponsors adopt an approach to identifying and managing areas of risk to mitigate potential issues and enhance overall success.
-
Time: A Crucial Factor In Therapeutics Development
4/21/2025
Accelerate your mRNA development and strengthen your response to emerging health threats with next-generation, cell-free DNA template solutions designed for speed, quality, and reliability.
-
Built Like A Tech Company: Why CROs Need A New Operating System
10/20/2025
See why building digital, automated infrastructure is essential, and better aligns CROs with today's speed, compliance, and innovation needs.
-
mRNA Research Services To Accelerate Your Project
10/9/2026
Codon optimization can speed early mRNA and LNP projects by weighing manufacturability, stability, and expression upfront, with research-stage work shaped around the end goal of scalable, low-immunogenicity candidates.
-
CDMO Or No CDMO... That Is The Question
12/12/2025
Success depends on assessing internal capabilities and knowing when outsourcing can accelerate timelines. Learn how strategic decisions reduce risk, avoid costly delays, and keep your organization competitive.
-
The Fast Track To Global Expansion: Consistency Across Every Site
8/27/2026
Operational consistency across global facilities protects product integrity and supports growth. Standardized processes reduce risk, minimize variability, and strengthen quality across markets.
-
Partnering For Success: Microbiological Testing In Contract Laboratories
8/12/2026
Outsourcing microbiological testing goes beyond method selection. Learn how early lab engagement, redundancy planning, and regulatory alignment protect your release timelines and compliance.
-
3 Services Your Biopharmaceutical Supply Chain Partner Should Offer
5/31/2023
Finding an experienced partner dedicated to reducing risk of contamination and capable of growing with you as project advances through clinical trial stages is essential.
-
Setting The Benchmark For Quality In Cell And Gene Therapy Logistics
12/29/2025
ISO 21973 defines global best practices for transporting cell and gene therapies, ensuring safety, quality, and consistency across complex supply chains vital to patient care.